Artemisinin, a potential option to inhibit inflammation and angiogenesis in rosacea

X. Yuan, J. Li, Y. Li, Z. Deng, L. Zhou, J. Long, Y. Tang, Z. Zuo, Y. Zhang, and H. Xie

doi:10.1016/j.biopha.2019.109181

Abstract

Rosacea is a facial chronic inflammatory skin disease with dysfunction of immune and vascular system. Artemisinin (ART), an anti-malaria drug, was reported to have several effects including anti-inflammation and anti-angiogenesis activities. However, the role of ART on rosacea remains unclear.

← Back to publications